Enzo Biochem Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Update
12 oct. 2021 07h00 HE
|
Enzo Biochem, Inc.
FY 2021 revenues of $117.7 million vs. $76.0 million, an increase of 55% YoY 4Q 2021 revenues of $24.8 million vs. $19.5 million a year ago, an increase of 27%FY 2021 EPS of $0.16 per share compared...
Enzo Biochem to Report Fourth Quarter and Full Year 2021 Financial Results and Business Update on Tuesday, October 12th
28 sept. 2021 08h00 HE
|
Enzo Biochem, Inc.
Conference Call and Webcast Scheduled for October 12, 2021, 8:30 am ET NEW YORK, NY, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics...
ENZO BIOCHEM TO PRESENT AT THE H.C. WAINWRIGHT 23RD ANNUAL GLOBAL INVESTMENT CONFERENCE
02 sept. 2021 16h05 HE
|
Enzo Biochem, Inc.
NEW YORK, NY, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, today announced that management will present at the H.C. Wainwright...
ENZO BIOCHEM RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR RAPID EXTRACTION METHOD ON PROPRIETARY TEST SYSTEM FOR DETECTION OF CORONAVIRUS SARS-CoV-2
20 juil. 2021 08h00 HE
|
Enzo Biochem, Inc.
NEW YORK, NY, July 20, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, announced today that it has received an...
Enzo Biochem Announces Online Service with TrustAssure to Schedule Timely PCR Testing Required for International Travel
15 juin 2021 12h00 HE
|
Enzo Biochem, Inc.
Testing will be available through CLX Health’s TrustAssure™ Global Testing Platform for international travelers from New York and New Jersey who will need to complete testing immediately prior to...
Enzo Biochem Reports Third Quarter Fiscal 2021 Results
09 juin 2021 16h05 HE
|
Enzo Biochem, Inc.
Total third quarter revenue of $32.8 million, a record quarterly high, increased 94% year-over-year Consolidated quarterly gross margin was 49% versus 26% in the previous year period, confirming...
Enzo Biochem to Report Third Quarter 2021 Financial Results on Wednesday, June 9
01 juin 2021 16h05 HE
|
Enzo Biochem, Inc.
NEW YORK, NY, June 01, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, announced today that it will report third quarter 2021 financial results...
Enzo’s Universal AMPICOLLECT™ Used on GENFLEX® Molecular Platform Cleared for Distribution by FDA Under Emergency Use Authorization
21 avr. 2021 08h00 HE
|
Enzo Biochem, Inc.
Company’s specimen collection kit now available for use in COVID-19 testing in the U.S. Sample collection kit can be used with PCR based molecular diagnostic or antigen-based testing platforms ...
ENZO BIOCHEM TO PRESENT AT THE KEYBANC CAPITAL MARKETS' LIFE SCIENCES & MEDTECH INVESTOR FORUM
17 mars 2021 16h15 HE
|
Enzo Biochem, Inc.
NEW YORK, NY, March 17, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, today announced that management will present at the KeyBanc Capital...
Enzo Biochem Reports Second Quarter Fiscal 2021 Results; Company Provides Leadership and Corporate Updates
15 mars 2021 16h05 HE
|
Enzo Biochem, Inc.
Total second quarter revenue of $31.5 million increased 62% year-over-year on continued recovery and expansion from impact of COVID-19 pandemicSecond quarter clinical laboratory revenue of $24.0...